Epigenetic activation of the prostaglandin receptor EP4 promotes resistance to endocrine therapy for breast cancer

Approximately 75% of breast cancers express estrogen receptor α (ERα) and depend on estrogen signals for continued growth. Aromatase inhibitors (AIs) prevent estrogen production and inhibit estrogen receptor signaling, resulting in decreased cancer recurrence and mortality. Advanced tumors treated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiken, Jeffrey F., McDonald, James I., Decker, Keith F., Sanchez, Cesar, Hoog, Jeremy, VanderKraats, Nathan D., Jung, Kyle L., Akinhanmi, Margaret, Rois, Lisa E., Ellis, Matthew J., Edwards, John R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398938/
https://www.ncbi.nlm.nih.gov/pubmed/27869171
http://dx.doi.org/10.1038/onc.2016.397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398938/
https://www.ncbi.nlm.nih.gov/pubmed/27869171
http://dx.doi.org/10.1038/onc.2016.397

Ejemplares similares